Target intelligence / Profile preview

Protein tyrosine phosphatase localized to the mitochondrion 1 (PTPMT1)

Target
PTPMT1
Molecular classification
Enzyme, Protein tyrosine phosphatase, Dual-specificity phosphatase, Mitochondrial protein
01

Overview

Protein tyrosine phosphatase localized to the mitochondrion 1 (PTPMT1) is a dual-specificity phosphatase exclusively localized to the mitochondrial inner membrane, with a critical role in the biosynthesis of cardiolipin by dephosphorylating phosphatidylglycerol phosphate. It is indispensable for mitochondrial integrity, respiration, and proper embryonic development, as knockout models result in embryonic lethality and severe mitochondrial dysfunction. While it belongs to the protein tyrosine phosphatase family, its endogenous substrate is a lipid intermediate, not a protein. PTPMT1 is being studied as a potential target for mitochondrial-related diseases, but direct pharmacological modulators are in early-stage research.

Other names
PTPMT1Protein tyrosine phosphatase, mitochondrial 1PTEN-like mitochondrial phosphataseSome literature may use “PTPMT1” in all caps
02

Mechanism of action

Inhibition of phosphatidylglycerol phosphate dephosphorylation, impacting cardiolipin biosynthesis. General mechanisms for PTP inhibitors: block dephosphorylation activity, modulate mitochondrial lipid metabolism.

03

Biological functions

Cardiolipin biosynthesisMitochondrial respiration regulationMitochondrial morphology and integrityIndirectly involved in cell death and embryogenesis (due to mitochondrial function)
04

Disease associations

Mitochondrial disordersEmbryonic lethality/early developmentPotential link to diseases with mitochondrial dysfunction (cardiomyopathies, metabolic disease)
05

Safety considerations

Potential for mitochondrial dysfunction if inhibited systemically, as PTPMT1 is essential for mitochondrial functionEmbryonic lethality in knockout models indicates high risk of severe toxicity
06

Interacting drugs

No clinically approved direct drugs identified, but experimental small-molecule inhibitors studied for protein tyrosine phosphatases in general

1 more in the full profile.

07

Biomarkers

No clinically validated biomarkers specific to PTPMT1reduced cardiolipin levelsaccumulation of phosphatidylglycerophosphate

Beyond the preview

Go deeper on Protein tyrosine phosphatase localized to the mitochondrion 1 (PTPMT1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Protein tyrosine phosphatase localized to the mitochondrion 1 (PTPMT1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call